UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007475
Receipt No. R000008808
Scientific Title A randomized phase II study of Erlotinib with or without Bevacizumab in NSCLC patients previouly treated with platinum-based chemotherapy containing bevacizumab. North Japan Lung Cancer Study Group Trial 1201
Date of disclosure of the study information 2012/03/09
Last modified on 2014/09/09 11:51:33

No. Disposal Last modified on Item of update
1 Insert 2012/03/09 16:37:52
2 Update 2012/03/29 08:58:34 Recruitment status
3 Update 2013/01/07 16:50:11 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
4 Update 2013/03/01 12:48:41 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
5 Update 2013/03/11 12:51:10 Email1
6 Update 2013/09/09 12:42:53 Address
TEL
Email
Address
Address
TEL
Address
7 Update 2014/09/09 11:51:33 Recruitment status


Contact us.